What's new

Human medicines European public assessment report (EPAR): Dyrupeg, pegfilgrastim, Date of authorisation: 28/03/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Dyrupeg, pegfilgrastim, Date of authorisation: 28/03/2025, Revision: 1, Status: Authorised

Apr 25, 2025 - 12:23
 0
Human medicines European public assessment report (EPAR): Dyrupeg, pegfilgrastim, Date of authorisation: 28/03/2025, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Dyrupeg, pegfilgrastim, Date of authorisation: 28/03/2025, Revision: 1, Status: Authorised
Read More

Tags:

Previous Article

Electric Range Rover completes Arctic Circle trials

Next Article

U.S. Air Force to Establish Second Super Squadron at Osan AB

Related Posts

Human medicines European public assessment report (EPAR): Vevizye, ciclosporin, Date of authorisation: 19/09/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 19, 2025  0

Summary of opinion: Kalydeco, 27/02/2025 Positive

Summary of opinion: Kalydeco, 27/02/2025 Positive

Feb 28, 2025  0

Human medicines European public assessment report (EPAR): Ultibro Breezhaler, indacaterol,glycopyrronium bromide, Date of authorisation: 19/09/2013, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 11, 2025  0